Clinical outcomes of systemic therapy for hemodialysis patients with metastatic renal cell carcinoma

被引：0
|
作者：
Iwasa, S. [1 ]
Mizuno, R. [1 ]
Yasumizu, Y. [1 ]
Tanaka, N. [1 ]
Takeda, T. [1 ]
Matsumoto, K. [1 ]
Morita, S. [1 ]
Kosaka, T. [1 ]
Asanuma, H. [1 ]
Oya, M. [1 ]
机构：
[1] Keio Univ, Sch Med, Dept Urol, Shinjuku Ku, Keio, Japan
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.10.178
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
143P
引用
收藏
页码：S1488 / S1488
页数：1
相关论文
共 50 条
  • [21] Systemic therapy after cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma
    Low, W. X. A.
    Gu, T.
    Lim, K. S. J.
    Yuen, S. P. J.
    Lee, L. S.
    Toh, C. K.
    Kanesvaran, R.
    Tan, H. S.
    Huang, H. H.
    Lau, K. O. W.
    BJU INTERNATIONAL, 2015, 115 : 12 - 13
  • [22] Systemic therapy for patients with advanced, unresectable or metastatic renal cell carcinoma: moving to guidelines
    Hotte, Sebastien J.
    Kapoor, Anil K.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2007, 1 (02): : S34 - S40
  • [23] Systemic Therapy in Patients With Metastatic Xp11.2 Translocation Renal Cell Carcinoma
    Yan, Xieqiao
    Zhou, Li
    Li, Siming
    Wu, Xiaowen
    Cui, Chuanliang
    Chi, Zhihong
    Si, Lu
    Kong, Yan
    Tang, Bixia
    Li, Caili
    Mao, Lili
    Wang, Xuan
    Lian, Bin
    Bai, Xue
    Dai, Jie
    Guo, Jun
    Sheng, Xinan
    CLINICAL GENITOURINARY CANCER, 2022, 20 (04) : 354 - 362
  • [24] Integration of surgery and systemic targeted therapy in the management of patients with metastatic renal cell carcinoma
    Wood, Christopher G.
    INTERNATIONAL JOURNAL OF UROLOGY, 2010, 17 : A108 - A108
  • [25] Outcomes following cytoreductive nephrectomy without immediate postoperative systemic therapy for patients with synchronous metastatic renal cell carcinoma
    Andrews, Jack R.
    Lohse, Christine M.
    Boorjian, Stephen A.
    Leibovich, Bradley C.
    Thompson, Houston
    Costello, Brian A.
    Bhindi, Bimal
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (04) : 166.e1 - 166.e8
  • [26] Clinical utility of biomarkers of systemic inflammation for patients with metastatic renal cell carcinoma.
    Harris, Wayne
    Akbashev, Mikhail Y.
    Kucuk, Omer
    Liu, Yuan
    Hsiao, Wayland
    Osunkoya, Adeboya O.
    Baumgarten, Deborah O.
    Master, Viraj A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [27] CLINICAL OUTCOMES OF PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) WITH OR WITHOUT SARCOMATOID DIFFERENTIATION TREATED WITH SYSTEMIC THERAPY IN REAL-WORLD CANADIAN SETTING
    Bou-Nehme, Sawaya G.
    Dragomir, A.
    Kollmannsberger, C.
    Basappa, N. S.
    Kapoor, A.
    Soulieres, D.
    Finelli, A.
    Heng, D. Y. C.
    Wood, L.
    Castonguay, V
    Canil, C.
    Winquist, E.
    Graham, J.
    Bjarnason, G. A.
    Bhindi, B.
    Lalani, A. K.
    Pouliot, F.
    Breau, R. H.
    Tanguay, S.
    VALUE IN HEALTH, 2022, 25 (12) : S39 - S39
  • [28] Outcomes of Patients With Metastatic Renal Cell Carcinoma and Bone Metastases in the Targeted Therapy Era
    Kalra, Sarathi
    Verma, Jonathan
    Atkinson, Bradley J.
    Matin, Surena F.
    Wood, Christopher G.
    Karam, Jose A.
    Lin, Sue-Hwa
    Satcher, Robert L.
    Tamboli, Pheroze
    Sircar, Kanishka
    Rao, Priya
    Corn, Paul G.
    Tannir, Nizar M.
    Jonasch, Eric
    CLINICAL GENITOURINARY CANCER, 2017, 15 (03) : 363 - 370
  • [29] Modern Systemic Therapy for Metastatic Renal Cell Carcinoma of the Clear Cell Type
    Parikh, Mamta
    Lara, Primo N., Jr.
    ANNUAL REVIEW OF MEDICINE, VOL 69, 2018, 69 : 209 - 221
  • [30] Clinical outcomes among unresectable, locally advanced, and metastatic cutaneous squamous cell carcinoma patients treated with systemic therapy
    Cowey, C. Lance
    Robert, Nicholas J.
    Espirito, Janet L.
    Davies, Kalatu
    Frytak, Jennifer
    Lowy, Israel
    Fury, Matthew G.
    CANCER MEDICINE, 2020, 9 (20): : 7381 - 7387
12345